Related Experiment Video
Updated: May 4, 2026

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
Cardiac dysfunction after aneurysmal subarachnoid hemorrhage: relationship with outcome.
Ivo van der Bilt1, Djo Hasan, Renee van den Brink
1From the Departments of Cardiology (I.v.d.B, D.H., R.v.d.B., A.W.) and Intensive Care (J.H.), Academic Medical Center Amsterdam; Department of Cardiology (M.-J.C.), University Medical Center Utrecht; Departments of Intensive Care (M.v.d.J.), Neurology (F.v.K.), and Cardiology (F.t.C.), Erasmus Medical Center Rotterdam; Departments of Intensive Care (J.M.), Cardiology (M.v.d.B.), and Neurosurgery (R.G.), University Medical Center Groningen; Departments of Cardiology (O.K.) and Intensive Care (J.G.), VU University Medical Center; Department of Cardiology (M.G.), Haga Hospital The Hague; Department of Neurosurgical Center Amsterdam (P.V.), Academic Medical Center and VU University Medical Center; Department of Clinical Epidemiology (A.A.), Julius Center for Health Sciences and Primary Care; Departments of Neurology and Neurosurgery (A.A., G.R.), Utrecht Stroke Center, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht; and Stichting CardioZorg (F.V.), Amsterdam, the Netherlands.
Cardiac abnormalities like wall motion abnormalities (WMAs) after aneurysmal subarachnoid hemorrhage (aSAH) independently predict poor outcomes and delayed cerebral ischemia (DCI). These findings highlight the need for targeted treatments for aSAH-related cardiac issues.
Area of Science:
- Neurology
- Cardiology
- Critical Care Medicine
Background:
- Aneurysmal subarachnoid hemorrhage (aSAH) can lead to cardiac complications.
- The association between cardiac abnormalities and outcomes like delayed cerebral ischemia (DCI) after aSAH requires further investigation.
Purpose of the Study:
- To determine if cardiac abnormalities following aSAH are independently associated with DCI and clinical outcomes.
- To identify specific cardiac markers that predict adverse events after aSAH.
Main Methods:
- Prospective, multicenter cohort study involving 301 patients with aSAH.
- Echocardiography, ECG, and biochemical markers for myocardial damage were assessed.
- Multivariable Poisson regression and survival analysis were used to evaluate outcomes including DCI, death, and poor clinical outcome at 3 months.
Main Results:
- Wall motion abnormalities (WMAs) were associated with increased risk of death and poor outcome (RR 1.8-2.3).
- Midventricular WMAs showed a significant association with death (RR 2.3) and poor outcome (RR 2.2).
- While ECG changes and troponin levels correlated with death, they were not independent predictors.
Conclusions:
- Echocardiographic WMAs are independent risk factors for clinical outcomes after aSAH.
- The increased risk of DCI partially explains the association between WMAs and poor outcomes.
- Further research into treatment strategies for aSAH-related cardiac abnormalities is warranted to improve patient outcomes.
More Related Videos
09:14Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
09:00The Rabbit Blood-shunt Model for the Study of Acute and Late Sequelae of Subarachnoid Hemorrhage: Technical Aspects
Published on: October 2, 2014
Related Concept Videos
Aneurysm III: Interprofessional Care
Hemorrhagic Stroke ll: Pathophysiology
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm IV: Nursing Management
Aneurysm I: Introduction
Hemorrhagic Stroke l: Introduction